"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 3 | 4 | 7 |
| 1997 | 1 | 2 | 3 |
| 1998 | 3 | 4 | 7 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 2 | 4 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 5 | 3 | 8 |
| 2005 | 4 | 3 | 7 |
| 2006 | 6 | 3 | 9 |
| 2007 | 12 | 5 | 17 |
| 2008 | 5 | 2 | 7 |
| 2009 | 7 | 6 | 13 |
| 2010 | 4 | 5 | 9 |
| 2011 | 5 | 5 | 10 |
| 2012 | 9 | 0 | 9 |
| 2013 | 8 | 14 | 22 |
| 2014 | 9 | 8 | 17 |
| 2015 | 7 | 6 | 13 |
| 2016 | 9 | 14 | 23 |
| 2017 | 13 | 4 | 17 |
| 2018 | 20 | 6 | 26 |
| 2019 | 13 | 3 | 16 |
| 2020 | 16 | 12 | 28 |
| 2021 | 10 | 18 | 28 |
| 2022 | 2 | 17 | 19 |
| 2023 | 2 | 7 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Desirability of Outcome Ranking and Response Adjusted for Antibiotic Risk (DOOR/RADAR) Post Hoc Analysis Supports Equipoise for Antibiotic Initiation Strategies in Intensive Care Unit-Acquired Pneumonia. Surg Infect (Larchmt). 2024 Apr; 25(3):221-224.
-
Guiding the Way: Traditional Medicinal Chemistry Inspiration for Rational Gram-Negative Drug Design. J Med Chem. 2024 Jan 11; 67(1):65-80.
-
The diagnostic dilemma for atypical presentation of progressive human Mpox. BMC Infect Dis. 2023 Dec 05; 23(1):850.
-
Diagnostic and Treatment Practices for Helicobacter Pylori Infection in an Academic Pediatric Hospital. R I Med J (2013). 2023 Jul 05; 106(6):35-39.
-
Design and Development of Robust, Daylight-Activated, and Rechargeable Biocidal Polymeric Films as Promising Active Food Packaging Materials. ACS Appl Bio Mater. 2023 06 19; 6(6):2459-2467.
-
Therapeutic potential of Bacillus phage lysin PlyB in ocular infections. mSphere. 2023 08 24; 8(4):e0004423.
-
Appraisal of Fungus-Derived Xanthoquinodins as Broad-Spectrum Anti-Infectives Targeting Phylogenetically Diverse Human Pathogens. J Nat Prod. 2023 Jun 23; 86(6):1596-1605.
-
Mechanical and antibacterial properties of an experimental flowable composite containing Nb2O5 and NF_TiO2 nanoparticles. J Mech Behav Biomed Mater. 2023 Jul; 143:105919.
-
Breaking membrane barriers to neutralize E. coli and K. pneumoniae virulence with PEGylated branched polyethylenimine. Biochim Biophys Acta Biomembr. 2023 Aug; 1865(6):184172.
-
In Vitro Susceptibility and Resistance of Mycoplasma genitalium to Nitroimidazoles. Antimicrob Agents Chemother. 2023 04 18; 67(4):e0000623.